Commentary

Nonfasting lipid testing: the new standard for cardiovascular risk assessment

Pol Darras, Andre Mattman and Gordon A. Francis
CMAJ November 12, 2018 190 (45) E1317-E1318; DOI: https://doi.org/10.1503/cmaj.180804

Article Information

vol. 190 no. 45 E1317-E1318
DOI 
https://doi.org/10.1503/cmaj.180804
PubMed 
30420386
History 
  • Published online November 11, 2018.
Copyright & Usage 
© 2018 Joule Inc. or its licensors

Author Information

  1. Pol Darras, MD,
  2. Andre Mattman, MD,
  3. Gordon A. Francis, MD
  1. Division of Endocrinology and Metabolism (Darras, Francis), Department of Medicine; Department of Pathology and Laboratory Medicine (Mattman), and Centre for Heart Lung Innovation (Francis), St. Paul’s Hospital, University of British Columbia, Vancouver, BC
  1. Correspondence to: Gordon Francis, gordon.francis{at}hli.ubc.ca

Statistics from Altmetric.com

Usage statistics: November 2018 to January 2021

AbstractFullPdf
Nov 20180585129
Dec 201803918
Jan 20190159
Feb 201901310
Mar 20190235
Apr 2019064
May 2019021
Jun 2019045
Jul 20190115
Aug 2019040
Sep 2019051
Oct 2019021
Nov 20190418
Dec 201909411
Jan 202001186
Feb 202006911
Mar 202008314
Apr 20200256
May 2020011711
Jun 2020014312
Jul 2020014413
Aug 2020020218
Sep 2020025028
Oct 2020026919
Nov 2020029113
Dec 2020026016
Jan 2021024215

Cited By...

Back to top

In this issue

Canadian Medical Association Journal: 190 (45)
CMAJ
Vol. 190, Issue 45
12 Nov 2018

Article tools

Respond to this article
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Nonfasting lipid testing: the new standard for cardiovascular risk assessment
Pol Darras, Andre Mattman, Gordon A. Francis
CMAJ Nov 2018, 190 (45) E1317-E1318; DOI: 10.1503/cmaj.180804
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Collections